Is Blue Water Vaccines, Inc. (BWV) a Buy, Sell, or Hold?
NASDAQ : BWV
Blue Water Vaccines, Inc.
$0.1802 USD
-$0.01 (-6.97%)
- Volume
- 520.29K
- Average Volume
- 433.47K
- Market Capitalization
- $3.41M
- P/E Ratio
- -0.11
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $1.95
- Year Low
- $0.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.41
Company Overview
NASDAQ
Neil J. Campbell MA, MBA
Biotechnology
Healthcare
BWV
12
US
USD
Liquidity Metrics
0.02
1.41
1.37
1.21
0.00
Sales & Valuation
$815.37K
4.58
0.05
-0.34
-15.59
Profitability
-$16.56
-$14.03M
-1319.55%
-1319.48%
-105.46%
-65.41%
P/E Metrics
-0.11
0.00
0.00
Analyst Price Target & Rating
$4.00
$4.00
$4.00
0/5
2 Analysts
-95.50%
Financial Health Scores
-14.62
2/9
$1.26M
$14.83M
$3.08M
-$11.93M
Key Metrics (TTM)
-$209.29K
-0.28
0.02
1.41
-105.46%
-56.35%
-1719.78%
-304.65%
-3379 days
Company Executives
| Name | Title |
|---|---|
| Bruce Harmon | Chief Financial Officer |
| Erin Henderson | Chief Business Officer & Corporate Secretary |
| James R. Sapirstein | Interim Executive Chairman |
| Neil J. Campbell | President, Chief Executive Officer & Director |
| Frank A. Jaeger | Senior Vice President of Marketing & Business Development |
| Theodore Scott Yoho | Head of Business Development |
Poll Results
No votes yet today — be the first to share your view!
About Blue Water Vaccines, Inc. (NASDAQ:BWV) Stock
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio. ...
Frequently Asked Questions
-
What is the current Blue Water Vaccines, Inc. (BWV) stock price?
-
Blue Water Vaccines, Inc.(NASDAQ:BWV) stock price is $0.1802 in the last trading session. During the trading session, BWV stock reached the peak price of $1.95 while $0.1601 was the lowest point it dropped to. The percentage change in BWV stock occurred in the recent session was --6.97% while the dollar amount for the price change in BWV stock was -$0.01.
-
BWV's industry and sector of operation?
-
The NASDAQ listed BWV is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BWV?
-
Bruce Harmon | Chief Financial Officer
Erin Henderson | Chief Business Officer & Corporate Secretary
James R. Sapirstein | Interim Executive Chairman
Neil J. Campbell | President, Chief Executive Officer & Director
Frank A. Jaeger | Senior Vice President of Marketing & Business Development -
How many employees does BWV have?
-
Number of BWV employees currently stands at 12. BWV operates from 201 East Fifth Street, Cincinnati, OH 45202, US.
-
Link for BWV official website?
-
Official Website of BWV is: https://handayaniprima.com
-
How do I contact BWV?
-
BWV could be contacted at phone #513 620 4101 and can also be accessed through its website. BWV operates from 201 East Fifth Street, Cincinnati, OH 45202, US.
-
How many shares of BWV are traded daily?
-
The average number of BWV shares traded daily for last 3 months was 433.47K.
-
What is the market cap of BWV currently?
-
The market value of BWV currently stands at $3.41M with its latest stock price at $0.1802